Skip to main content

COVOVAX™

Product overview

Vaccine type
Covid-19
Commercial Name
COVOVAX™
Manufacturer
Serum Institute of India Pvt. Ltd.
Manufacturer Country
India
Responsible NRA
Central Drugs Standard Control Organization
Country
India

Prequalification

Prequalification Status
Current
Effective Date

Product description

Pharmaceutical Form
Liquid: ready to use
Presentation
Vial
Number of Doses
1
Diluent
Not Applicable
Route of Administration
Intramuscular
Shelf Life
9 months
Storage Temperature
2 °C – 8 °C
Secondary Packaging
Carton of 50 vials (50 doses) [Dimensions: 18.5 x 9.5 x 4.0 cm]
Tertiary Packaging
Box containg 6 cartons of 50 vials (300 vials/300 doses) [Dimensions: 31 x 19 x 9.3 cm]
Multidose Vial Policy
Not applicable
Vaccine Preservative
none
Cold Chain Volume
15.82 cm3/dose (in secondary packaging)

Attachments

Container Photo
Package Insert (XBB.1.5)
WHO PUBLIC ASSESSMENT REPORT - WHOPAR